The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30

被引:574
作者
King, MT
机构
[1] Ctr. for Hlth. Econ. Res. and Eval., Westmead Hospital, Westmead
关键词
cancer; clinical importance; effect size; interpretations; quality of life; statistical significance;
D O I
10.1007/BF00439229
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
While quality of life (QOL) assessment is becoming more Common, interpreting the results remains problematic. This paper demonstrates an approach to developing clinically-based interpretations for QOL outcomes, using the QLQ-C30 as an example. The results from 14 published QLQ-C30 studies which group patients by performance status, weight loss, toxicity, extent or severity of disease are collated. Groups with tower clinical status generally have worse QOL. The largest differences are between performance status groups, and the smallest differences are between groups of patients with local disease and those with metastases. The physical and role scores have the largest ranges of means across patient groups, and show the largest differences between clinical groups, while the cognitive and emotional scores have the smallest ranges of means and differences. Sicker groups have larger score standard deviations than healthier groups. Relatively large and small means and differences, and corresponding effect sizes, are presented. Collectively, the results provide a sense of the relative sizes of means and of differences, and of the types of clinical groups which give rise to them, thereby providing clinically-based benchmarks by which to interpret QLQ-C30 results.
引用
收藏
页码:555 / 567
页数:13
相关论文
共 35 条
  • [1] THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY
    AARONSON, NK
    AHMEDZAI, S
    BERGMAN, B
    BULLINGER, M
    CULL, A
    DUEZ, NJ
    FILIBERTI, A
    FLECHTNER, H
    FLEISHMAN, SB
    DEHAES, JCJM
    KAASA, S
    KLEE, M
    OSOBA, D
    RAZAVI, D
    ROFE, PB
    SCHRAUB, S
    SNEEUW, K
    SULLIVAN, M
    TAKEDA, F
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) : 365 - 376
  • [2] Aaronson NK., 1996, QUALITY LIFE PHARMAC
  • [3] Aaronson NK, 1991, EFFECT CANC QUALITY, P185
  • [4] [Anonymous], 1995, LANCET, V1, P1
  • [5] QUALITY-OF-LIFE DURING CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER .2. A LONGITUDINAL-STUDY OF THE EORTC-CORE-QUALITY-OF-LIFE-QUESTIONNAIRE AND COMPARISON WITH THE SICKNESS IMPACT PROFILE
    BERGMAN, B
    SULLIVAN, M
    SORENSON, S
    [J]. ACTA ONCOLOGICA, 1992, 31 (01) : 19 - 28
  • [6] PSYCHOMETRIC VALIDATION OF THE EORTC CORE QUALITY-OF-LIFE QUESTIONNAIRE, 30-ITEM VERSION AND A DIAGNOSIS-SPECIFIC MODULE FOR HEAD AND NECK-CANCER PATIENTS
    BJORDAL, K
    KAASA, S
    [J]. ACTA ONCOLOGICA, 1992, 31 (03) : 311 - 321
  • [7] QUALITY-OF-LIFE IN PATIENTS TREATED FOR HEAD AND NECK-CANCER - A FOLLOW-UP-STUDY 7 TO 11 YEARS AFTER RADIOTHERAPY
    BJORDAL, K
    KAASA, S
    MASTEKAASA, A
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 28 (04): : 847 - 856
  • [8] QUALITY-OF-LIFE MEASUREMENT IN PATIENTS WITH ESOPHAGEAL CANCER
    BLAZEBY, JM
    WILLIAMS, MH
    BROOKES, ST
    ALDERSON, D
    FARNDON, JR
    [J]. GUT, 1995, 37 (04) : 505 - 508
  • [9] QUALITY-OF-LIFE DURING PELVIC RADIOTHERAPY
    BYE, A
    OSE, T
    KAASA, S
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1995, 74 (02) : 147 - 152
  • [10] ESTIMATING SAMPLE SIZES FOR BINARY, ORDERED CATEGORICAL, AND CONTINUOUS OUTCOMES IN 2 GROUP COMPARISONS
    CAMPBELL, MJ
    JULIOUS, SA
    ALTMAN, DG
    [J]. BRITISH MEDICAL JOURNAL, 1995, 311 (7013) : 1145 - 1148